Breaking News Instant updates and real-time market news.

IRWD

Ironwood

$10.92

-0.09 (-0.82%)

, AGN

Allergan

$121.88

-0.59 (-0.48%)

08:33
06/03/19
06/03
08:33
06/03/19
08:33

Ironwood, Allergan initiate dosing in Phase II clinical trial of MD-7246

Ironwood Pharmaceuticals (IRWD) announced the initiation of patient dosing in a Phase II clinical trial evaluating MD-7246 in patients with abdominal pain associated with irritable bowel syndrome with diarrhea. Data from the Phase II trial are expected in the second half of 2020. Ironwood and Allergan (AGN) are evaluating MD-7246, an investigational new product, as an oral, intestinal, non-opioid, pain-relieving agent for patients suffering from abdominal pain associated with certain GI diseases. MD-7246 is a delayed-release formulation of linaclotide designed to provide targeted delivery of linaclotide to the colon, where the majority of the abdominal pain associated with IBS-D is believed to originate, and to limit fluid secretion in the small intestine resulting in minimal impact on bowel function.

IRWD

Ironwood

$10.92

-0.09 (-0.82%)

AGN

Allergan

$121.88

-0.59 (-0.48%)

  • 04

    Jun

IRWD Ironwood
$10.92

-0.09 (-0.82%)

02/25/19
HCWC
02/25/19
UPGRADE
Target $14
HCWC
Neutral
Ironwood upgraded to Neutral from Sell at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju upgraded Ironwood Pharmaceuticals to Neutral and raised his price target for the shares to $14 from $11.50. The analyst anticipates "moderate growth" in Linzess within the U.S. market going forward, as well as accelerating contributions from ex-U.S. territories, particularly China. Ironwood's performance in the most recent quarter handily beats estimates, he points out.
02/26/19
SPIN
02/26/19
INITIATION
Target $18
SPIN
Buy
Ironwood initiated with a Buy at Spin-Off Research
Spin-Off Research initiated Ironwood with a Buy and $18 price target.
03/27/19
MSCO
03/27/19
UPGRADE
MSCO
Equal Weight
Ironwood upgraded to Equal Weight from Underweight at Morgan Stanley
03/27/19
MSCO
03/27/19
UPGRADE
Target $14
MSCO
Equal Weight
Morgan Stanley upgrades Ironwood to Equal Weight on more stable Linzess growth
Morgan Stanley analyst David Lebowitz upgraded Ironwood to Equal Weight from Underweight, citing his view that Linzess growth will stabilize after multiple quarters of deceleration. The withdrawal of generic MiraLAX in November 2018 will bring new patients in the near-term and new Phase 3 data expected by mid year should allow for new claims of reducing pain, discomfort and bloating, which Lebowitz thinks will bring new patients on board and help sales. Additionally, the company's spinoff of Cyclerion, expected to be completed on April 1, should lower costs and contribute to profitability, the analyst said. He raised his price target on Ironwood shares to $14 from $11.
AGN Allergan
$121.88

-0.59 (-0.48%)

05/10/19
RHCO
05/10/19
NO CHANGE
Target $170
RHCO
Buy
Allergan price target lowered to $170 from $178 at SunTrust
SunTrust analyst Gregg Gilbert lowered his price target on Allergan (AGN) to $170 after its Q1 results, modeling more conservative sales growth for its Botox from the entry of a new competitor Evolus (EOLS) into U.S. markets. The analyst also keeps his Buy rating on Allergan, stating that while he "shares" investors' frustration with its underperformance, he sees the valuation on the stock as reflective of its competitive threats and uninspiring pipeline. Gilbert anticipates an "attractive return" from Allergan over the next 12 months if the company can meet or exceed its financial targets or produce '"even mixed pipeline success."
05/17/19
LSCM
05/17/19
NO CHANGE
Target $10
LSCM
Buy
Allergan ruling removes overhang on Harrow Health, says Lake Street
Lake Street analyst Brooks O'Neil believes the ruling yesterday in the case of Allergan (AGN) versus Imprimis Pharmaceuticals removes a "significant overhang" on shares of Harrow Health (HROW) and the entire compounding industry. Observers believed that if big pharma can use the Lanham Act to police compliance, as opposed to relying on government regulations, there could be serious implications for manufacturers of lower-cost, compounded medicines, O'Neil tells investors in a research note. He reiterates a Buy rating on Harrow Health with a $10 price target.
05/28/19
GSCO
05/28/19
INITIATION
Target $154
GSCO
Neutral
Allergan initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Terence Flynn started Allergan with a Neutral rating and $154 price target. The analyst finds the company's non-migraine pharma pipeline "generally underwhelming" and believes its leverage profile "somewhat limits" its capital allocation flexibility.
05/29/19
WELS
05/29/19
NO CHANGE
Target $188
WELS
Outperform
Allergan selloff on opioid concerns an overreaction, says Wells Fargo
Wells Fargo analyst David Maris attributes the 5% selloff today in shares of Allergan (AGN) to heightened fears of opioid liability risks in the sector. Maris spoke to Allergan's investor relations team, which noted the company is fully indemnified regarding legacy Actavis generics issues. Further, Allergan has very little exposure to branded opioid sales, as they represent a very small percentage of the company's branded business, Maris tells investors in a research note. He believes the decline in Allergan shares is an overreaction to the negative headlines related to opioid-based litigation facing a number of specialty pharma companies such as Teva (TEVA), Mylan (MYL), and Mallinckrodt (MNK). Maris calls the selloff overdone and recommends buying shares of Allergan. He keeps an Outperform rating on the name with a $188 price target.

TODAY'S FREE FLY STORIES

ATNI

ATN International

11:46
10/16/19
10/16
11:46
10/16/19
11:46
Initiation
ATN International initiated  »

ATN International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

AGYS

Agilysys

$25.64

-0.67 (-2.55%)

11:46
10/16/19
10/16
11:46
10/16/19
11:46
Initiation
Agilysys initiated  »

Agilysys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BCS

Barclays

$8.40

0.055 (0.66%)

11:45
10/16/19
10/16
11:45
10/16/19
11:45
Options
Barclays call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 12

    Nov

GM

General Motors

$36.73

0.46 (1.27%)

11:43
10/16/19
10/16
11:43
10/16/19
11:43
Hot Stocks
GM shares up over 2% after UAW sends tentative deal to members to ratify »

Shares of General Motors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

COMM

CommScope

$11.35

0.02 (0.18%)

11:42
10/16/19
10/16
11:42
10/16/19
11:42
Hot Stocks
CommScope patents upheld by German federal patent court »

The German Federal Patent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
10/16/19
10/16
11:40
10/16/19
11:40
General news
Fed's Evans is keeping an open mind with respect to another rate cut »

Fed's Evans is…

INCY

Incyte

$78.39

-0.13 (-0.17%)

11:39
10/16/19
10/16
11:39
10/16/19
11:39
Recommendations
Incyte analyst commentary  »

Incyte REACH2 wins on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

CSTM

Constellium

$14.03

0.31 (2.26%)

, BLL

Ball Corp.

$72.15

0.02 (0.03%)

11:38
10/16/19
10/16
11:38
10/16/19
11:38
Recommendations
Constellium, Ball Corp., Alcoa analyst commentary  »

Constellium a potential…

CSTM

Constellium

$14.03

0.31 (2.26%)

BLL

Ball Corp.

$72.15

0.02 (0.03%)

AA

Alcoa

$19.75

0.3 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 23

    Oct

  • 31

    Oct

GM

General Motors

$36.76

0.49 (1.35%)

11:37
10/16/19
10/16
11:37
10/16/19
11:37
Periodicals
General Motors, UAW reach proposed tentative agreement, CNN says »

CNN's Vanessa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BLL

Ball Corp.

$71.98

-0.15 (-0.21%)

11:35
10/16/19
10/16
11:35
10/16/19
11:35
Hot Stocks
Ball Corp. to build new $200M aluminum cups manufacturing plant in Georgia »

Ball Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

RNG

RingCentral

$167.20

-9.62 (-5.44%)

11:35
10/16/19
10/16
11:35
10/16/19
11:35
Options
Ringcentral put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 13

    Nov

CASY

Casey's General Stores

$161.02

0.13 (0.08%)

11:32
10/16/19
10/16
11:32
10/16/19
11:32
Hot Stocks
Casey's General Stores appoints Tom Brennan as chief merchandising officer »

Casey's General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

NOW

ServiceNow

$254.72

-19.88 (-7.24%)

, ADBE

Adobe

$270.00

-9.4 (-3.36%)

11:28
10/16/19
10/16
11:28
10/16/19
11:28
On The Fly
Adobe downgrade, Pure Storage upgrade among today's top analyst calls »

Check out today's top…

NOW

ServiceNow

$254.72

-19.88 (-7.24%)

ADBE

Adobe

$270.00

-9.4 (-3.36%)

PSTG

Pure Storage

$18.20

0.55 (3.12%)

COST

Costco

$297.73

-0.69 (-0.23%)

WDAY

Workday

$160.48

-20.36 (-11.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 29

    Oct

  • 04

    Nov

  • 12

    Dec

  • 17

    Dec

WDAY

Workday

$160.53

-20.31 (-11.23%)

, COUP

Coupa Software

$145.36

-9.41 (-6.08%)

11:26
10/16/19
10/16
11:26
10/16/19
11:26
On The Fly
Workday slides as Street digests analyst day »

Shares of Workday (WDAY)…

WDAY

Workday

$160.53

-20.31 (-11.23%)

COUP

Coupa Software

$145.36

-9.41 (-6.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 12

    Dec

IP

International Paper

$42.22

0.79 (1.91%)

11:25
10/16/19
10/16
11:25
10/16/19
11:25
Options
International Paper call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

11:25
10/16/19
10/16
11:25
10/16/19
11:25
Conference/Events
FBN Securities cannabis analysts to hold a luncheon meeting »

Analysts host Chairman…

11:25
10/16/19
10/16
11:25
10/16/19
11:25
Conference/Events
William Blair restaurant tech analyst to hold a group luncheon »

Restaurant Technology…

11:25
10/16/19
10/16
11:25
10/16/19
11:25
Conference/Events
Wedbush enterprise software analysts to hold an advisor luncheon »

Enterprise Software…

TCEHY

Tencent

$0.00

(0.00%)

11:18
10/16/19
10/16
11:18
10/16/19
11:18
Periodicals
'League of Legends' coming to consoles, mobile devices, Kotaku says »

Riot Games'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/16/19
10/16
11:17
10/16/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/16/19
10/16
11:16
10/16/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRBT

iRobot

$58.99

1.2 (2.08%)

11:15
10/16/19
10/16
11:15
10/16/19
11:15
Options
iRobot put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

CSCO

Cisco

$46.53

0.16 (0.35%)

11:05
10/16/19
10/16
11:05
10/16/19
11:05
Options
Cisco call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TMUS

T-Mobile

$79.88

0.13 (0.16%)

, S

Sprint

$6.46

-0.02 (-0.31%)

10:51
10/16/19
10/16
10:51
10/16/19
10:51
Hot Stocks
FCC commissioner Rosenworcel says T-Mobile, Sprint deal will raise prices »

Federal Communications…

TMUS

T-Mobile

$79.88

0.13 (0.16%)

S

Sprint

$6.46

-0.02 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

SIG

Signet Jewelers

$15.36

-0.39 (-2.48%)

10:50
10/16/19
10/16
10:50
10/16/19
10:50
Options
Call volume in Signet Jewelers spikes on large 3-way adjusting long »

Call volume in Signet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.